Position in GILD
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$983,430
+$138,848 QoQ
Shares Held
7,784
+28.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#1,074
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BECKER CAPITAL MANAGEMENT INC holds $223,808,539 across 11 Drug Manufacturers - General names. GILD ranks #10 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
246,132 | $62,510,144 | |
| 2 | MRK |
Merck & Co., Inc.
|
268,226 | $34,467,041 | |
| 3 | AZN |
Astrazeneca PLC
|
176,512 | $33,470,205 | |
| 4 | AMGN |
Amgen Inc
|
85,085 | $30,810,980 | |
| 5 | LLY |
ELI LILLY & Co
|
24,740 | $29,673,900 | |
| 6 | SNY |
Sanofi
|
346,469 | $14,780,367 | |
| 7 | PFE |
Pfizer Inc
|
469,672 | $11,309,701 | |
| 8 | ABBV |
AbbVie Inc.
|
15,542 | $3,910,988 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $983,430 | 7,784 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $844,582 | 6,060 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $763,933 | 6,224 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $691,752 | 6,232 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $729,413 | 6,579 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,030,747 | 9,199 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,046,459 | 11,329 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,420,584 | 16,944 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $1,185,580 | 17,280 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,400,540 | 19,120 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,735,558 | 21,424 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,704,735 | 22,748 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,213,604 | 28,722 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $3,056,034 | 36,833 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $12,801,351 | 149,113 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $15,879,993 | 257,416 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $16,373,221 | 264,896 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $22,634,517 | 380,732 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $27,660,706 | 380,949 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $28,015,787 | 401,085 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $25,105,391 | 364,586 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $23,430,507 | 362,533 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $21,038,676 | 361,117 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $24,002,026 | 379,839 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $29,799,015 | 387,302 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $36,693,703 | 490,820 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||